Has Taylor Simon received payments from drug or device companies?

Yes. Drug and device makers reported $4,563 in general payments to Taylor Simon across 195 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Taylor Simon did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Taylor Simon come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Taylor Simon

Psychiatric/Mental Health · Amherst, NYNPI 1972386746

Payments from drug & device makers

$4,563in general payments, 2019–2025

Across 195 payments — averaging $23.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Otsuka America Pharmaceutical, Inc.$728
Lundbeck LLC$512
Neurocrine Biosciences, Inc.$482
AbbVie$370
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$308
Alkermes, Inc.$303
plus $2K from 18 others

What the payments were for

Food & beverage$4,563100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Otsuka America Pharmaceutical, Inc.	27	$728
Lundbeck LLC	30	$512
Neurocrine Biosciences, Inc.	17	$482
AbbVie	15	$370
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	12	$308
Alkermes, Inc.	16	$303
Johnson & Johnson	8	$296
Vanda Pharmaceuticals Inc.	10	$262
Corium, LLC	8	$182
E.r. Squibb & Sons, L.L.C.	3	$164
Takeda Pharmaceuticals U.S.A., Inc.	9	$157
Idorsia Pharmaceuticals US Inc	9	$145
Teva Pharmaceuticals USA, Inc.	6	$143
Collegium Pharmaceutical, Inc.	6	$125
Axsome Therapeutics, Inc.	5	$122
Bausch Health US, LLC	2	$46
Almatica Pharma LLC	3	$42
Supernus Pharmaceuticals, Inc.	2	$41
Livanova USA, Inc.	2	$38
Biogen	1	$29
Novo Nordisk	1	$20
Neos Therapeutics, LP	1	$17
Noven Therapeutics, LLC	1	$16
Luye Pharma (USA) Ltd.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,563 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Duloxetine Hcl	12	$385
Bupropion XlBupropion Hcl	14	$272
Clonazepam	21	$174
Trazodone Hcl	11	$173
Alprazolam	18	$123
Buspirone Hcl	11	$78

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Amherst

Jeanne Salada-ConroyAmherst$10K
Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Mary OlsonNew York$142K
Elijah StevensBinghamton$131K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →